Clinical trials recruiting for Preeclampsia (PE)
14
Recruiting trials
13
US states with sites
9
Countries
36%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 12
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 17 OHPC | 1 |
| Pravastatin 40 mg | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Tennessee | 3 |
| Arizona | 1 |
| Delaware | 1 |
| Florida | 1 |
| Louisiana | 1 |
| Massachusetts | 1 |
| Mississippi | 1 |
| New Jersey | 1 |
| New York | 1 |
| North Carolina | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
Top cities
Knoxville, Tennessee 2Austin, Texas 1Boston, Massachusetts 1Camden, New Jersey 1Chattanooga, Tennessee 1Danville, Pennsylvania 1Galveston, Texas 1Glendale, Arizona 1Houston, Texas 1Jackson, Mississippi 1
Self-screener
Recruiting trials
- A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With Preeclampsia
- Cardiometabolic Disease and Substrate Metabolism
- Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications
- Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia
- Endothelial Dysfunction for Prognosis In Patients With preeClampSia
- Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)
- Non-Invasive Preeclampsia Screening and Biobank
- Preeclampsia: Origin, Characteristics and Effects on Mother and Baby
- Prevention of Preeclampsia in Denmark: A National Implementation Study
- Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
- Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
- Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)
- The Combined First Trimester Screening
- Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters
Related conditions
Trials recruiting for Preeclampsia (PE) often also study these conditions. Each links to its own recruiting-trial list.
Hypertension 1201Preeclampsia (PE) Risk 5Pregnancy Complications 25Preeclampsia 61Gestational Diabetes Mellitus in Pregnancy 5Gestational Diabetes 17Gestational Complications 3Preterm Labor 3Obesity and Obesity-related Medical Conditions 27Obesity 1512
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Preeclampsia (PE) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.